Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer
Qingzhu Yang, Kai Li, Xuemei Huang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 19, pp. 974-985
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Yuan Li, Zhiyuan Xu, Shanming Ruan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 260
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 130
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie, Man Chu, Gendi Song, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 303-318
Closed Access | Times Cited: 94
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
Milad Ashrafizadeh, Navid Rabiee, Alan Prem Kumar, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2181-2198
Closed Access | Times Cited: 54
The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role
Jing Zuo, Zhe Zhang, Maomao Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism
Yajun Luo, Wanping Xiang, Haohuan Li, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 53-65
Open Access | Times Cited: 39
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 29
Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways
Milad Ashrafizadeh, Ali Zarrabi, Sedigheh Saberifar, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 110-110
Open Access | Times Cited: 62
Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
Yunseo Woo, Hyo-Ji Lee, Young Mee Jung, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 54
LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway
Fengyu Xu, Mengqi Huang, Qingyong Chen, et al.
Cancer Research (2021) Vol. 81, Iss. 22, pp. 5678-5691
Open Access | Times Cited: 54
LncRNA as a multifunctional regulator in cancer multi-drug resistance
Jiaying He, Shaomi Zhu, Xin Liang, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 8, pp. 1-15
Closed Access | Times Cited: 49
The regulatory role of antisense lncRNAs in cancer
Biao Liu, Wei Xiang, Jiahao Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 47
Ferroptosis: a potential therapeutic target for stroke
Chengli Liu, Guijun Wang, Wenrui Han, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 988-997
Open Access | Times Cited: 18
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Myeong‐Jin Kim, Hyung Sun Kim, Hyeon Woong Kang, et al.
Cells (2023) Vol. 12, Iss. 20, pp. 2509-2509
Open Access | Times Cited: 16
Cancer stem cell fate determination: mito-nuclear communication
Mengchen Fan, Ying Shi, Jumei Zhao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
Influence of Mesalazine on Ferroptosis-Related Gene Expression in In Vitro Colorectal Cancer Culture
Joanna Słoka, Barbara Strzałka‐Mrozik, Sebastian Kubica, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 219-219
Open Access
Epigenetic Control of Redox Pathways in Cancer Progression
Vandit Shah, Hiu Yan Lam, Ching Leong, et al.
Antioxidants and Redox Signaling (2025)
Closed Access
Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer
Mengmeng Shi, Rui Zhang, Hui Lyu, et al.
Journal of Advanced Research (2025)
Open Access
The characteristics and roles of β‐TrCP1/2 in carcinogenesis
Yanli Bi, Danrui Cui, Xiufang Xiong, et al.
FEBS Journal (2020) Vol. 288, Iss. 11, pp. 3351-3374
Open Access | Times Cited: 46
Emerging roles of the solute carrier family in pancreatic cancer
Zijian Wu, Jin Xu, Liang Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 39
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
Chengjie Lin, Yan Wang, Yihong Dong, et al.
Biology Direct (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 24
Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters
Mehdi Rabiee Valashedi, Chia Bamshad, Nima Najafi-Ghalehlou, et al.
Human Cell (2022) Vol. 35, Iss. 4, pp. 972-994
Closed Access | Times Cited: 23
Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis
Xin Ye, Liping Wang, Cong Han, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 6, pp. 304-304
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top